CB1 has also been shown to inhibit voltage-gated Ca2+ channels and activate K+ currents, events known to reduce neuronal signaling, while reducing the release of nitric oxide (NO) via neuronal NO synthase (NOS), thus reducing vasodilation and migraine pain [80]. The gene discussed is CNR1; the disease is migraine disorder.